Predictive Factors of Long-Term Neurologic Outcome and Progression-Free Survival in Intramedullary Spinal Cord Tumors: A 10-year Single-Center Cohort Study and Review of the Literature
World Neurosurgery · 2024-07 · 187 · e94-e106
DOI: 10.1016/j.wneu.2024.04.024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift World Neurosurgery, 2024-07. Verfasst von Maria Pia Tropeano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Milan, Italy; Department of Neurosurgery, IRCCS Humanitas Research Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Spinal Cord Neoplasms, Progression-Free Survival. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Intramedullary spinal cord tumors (IMSCTs) are a rare subgroup of neoplasms, encompassing both benign, slow-growing masses, and malignant lesions; radical surgical excision represents the cornerstone of treatment for such pathologies regardless of histopathology, which, on the other hand, is a known predictor of survival and neurologic outcome postsurgery. The present study aims to investigate the relevance of other factors in predicting survival and long-term functional outcomes. METHODS: We conducted a review of current literature on functional outcomes of IMSCTs, as well as a 10-years prospective analysis of a wide cohort of patients with diagnosis of IMSCTs who underwent surgical resection at our institution. RESULTS: Our series encompasses 60 patients with IMSCTS, among which 36 ependymomas, 6 cavernous angiomas, 5 hemangioblastomas, 6 WHO Grade I-IV astrocytomas, 3 intramedullary spinal metastases and 4 miscellaneous tumors. GTR was achieved in 76,67% of patients, with high preoperative McCormick grade, syringomyelia and changes at neurophysiologic monitoring being the strongest predictors at multivariate analysis (P = 0.0027, P = 0.0017 and P = 0.001 respectively). CONCLUSIONS: Consistently with literature, preoperative neurologic function is the most important factor predicting long-term functional outcome (0.17, CI 0.069-0.57 with P = 0.0018), advocating for early surgery in the management of IMSCTs, whereas late complications such as myelopathy and neuropathic pain were present regardless of preoperative function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Milan, Italy; Department of Neurosurgery, IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Neurosurgery, IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: donatocreatura@gmail.com.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Zitieren
APA
Tropeano, M. P., Rossini, Z., Franzini, A., Baram, A., Creatura, D., Raspagliesi, L., Pessina, F., & Fornari, M. (2024). Predictive Factors of Long-Term Neurologic Outcome and Progression-Free Survival in Intramedullary Spinal Cord Tumors: A 10-year Single-Center Cohort Study and Review of the Literature. World Neurosurgery, 187, e94-e106. https://doi.org/10.1016/j.wneu.2024.04.024
Vancouver
Tropeano MP, Rossini Z, Franzini A, Baram A, Creatura D, Raspagliesi L, et al. Predictive Factors of Long-Term Neurologic Outcome and Progression-Free Survival in Intramedullary Spinal Cord Tumors: A 10-year Single-Center Cohort Study and Review of the Literature. World Neurosurgery. 2024;187:e94-e106. doi:10.1016/j.wneu.2024.04.024
BibTeX
@article{Tropeano2024,
author = {Tropeano, Maria Pia and Rossini, Zefferino and Franzini, Andrea and Baram, Ali and Creatura, Donato and Raspagliesi, Luca and Pessina, Federico and Fornari, Maurizio},
title = {Predictive Factors of Long-Term Neurologic Outcome and Progression-Free Survival in Intramedullary Spinal Cord Tumors: A 10-year Single-Center Cohort Study and Review of the Literature},
journal = {World Neurosurgery},
year = {2024},
volume = {187},
pages = {e94--e106},
doi = {10.1016/j.wneu.2024.04.024}
}
EUVIMED